Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAStem Cell Injection for Acute Exacerbation of Interstitial Lung Disease
CTR20231881Phase 2Active
- Sponsor
- Zehui Chenxing
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAStem cells in interstitial lung disease (ILD), sponsored by Zehui Chenxing. Started Jul 2023; status: active.
02
Drugs
CAStem cells
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on CTR20231881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231881.